| Dr Henri P Lanctin, | |
|
2351 Connecticut Avenue South, Suite 200, Sartell, MN 56377 | |
| (320) 259-1411 | |
| Not Available |
| Full Name | Dr Henri P Lanctin |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 41 Years |
| Location | 2351 Connecticut Avenue South, Sartell, Minnesota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1760425896 | NPI | - | NPPES |
| 340015396 | Other | MN | RAILROAD MEDICARE |
| 069722200 | Medicaid | MN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 41196 (Minnesota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Prairie Lakes Healthcare System, Inc | Watertown, SD | Hospital |
| Milbank Area Hospital/avera Health | Milbank, SD | Hospital |
| Ortonville Area Health Services | Ortonville, MN | Hospital |
| Sanford Medical Center Bismarck | Bismarck, ND | Hospital |
| Coteau Des Prairies Health Care System | Sisseton, SD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Prairie Lakes Health Care Systems Inc | 8628987823 | 85 |
| Sanford Bismarck | 9739098575 | 448 |
News Archive
Getting the word out is half the battle, and the state is well into a $3 million media campaign ... [E]very adult must have insurance by December. If they don't and if the state determines that insurance was affordable for them, they will be fined $219 next year. The penalty increases substantially in 2009.
In the US, child-resistant packaging for most medications has contributed to the prevention of thousands of pediatric deaths. Nevertheless, over 500,000 calls are made to poison control centers each year after accidental ingestion of medications by young children, and the number of emergency department visits for unsupervised medication ingestions is rising.
NicOx S.A. (NYSE Euronext Paris: COX) today announced that an important scientific article has been published in the September issue of the American Journal of Cardiology. The publication describes the blood pressure results from the 301 phase 3 study for naproxcinod in detail. Naproxcinod is the first-in-class Cyclooxygenase-Inhibiting Nitric Oxide Donating (CINOD) anti-inflammatory agent for the relief of the signs and symptoms of osteoarthritis (OA).
According to a new report by iData Research, the leading global authority in medical device and pharmaceutical market research, the retail European hearing aid and audiology device market was valued at over €3.8 billion in 2010, while the wholesale market was valued at almost €1.3 billion The retail market is expected to grow rapidly by 2017 due to aggressive growth strategies among local and international retail chains and the adoption of new technologies such as wireless Bluetooth hearing aids and receiver-in-canal models.
› Verified 3 days ago
| Entity Name | Prairie Lakes Health Care Systems Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720166002 PECOS PAC ID: 8628987823 Enrollment ID: O20040202000187 |
News Archive
Getting the word out is half the battle, and the state is well into a $3 million media campaign ... [E]very adult must have insurance by December. If they don't and if the state determines that insurance was affordable for them, they will be fined $219 next year. The penalty increases substantially in 2009.
In the US, child-resistant packaging for most medications has contributed to the prevention of thousands of pediatric deaths. Nevertheless, over 500,000 calls are made to poison control centers each year after accidental ingestion of medications by young children, and the number of emergency department visits for unsupervised medication ingestions is rising.
NicOx S.A. (NYSE Euronext Paris: COX) today announced that an important scientific article has been published in the September issue of the American Journal of Cardiology. The publication describes the blood pressure results from the 301 phase 3 study for naproxcinod in detail. Naproxcinod is the first-in-class Cyclooxygenase-Inhibiting Nitric Oxide Donating (CINOD) anti-inflammatory agent for the relief of the signs and symptoms of osteoarthritis (OA).
According to a new report by iData Research, the leading global authority in medical device and pharmaceutical market research, the retail European hearing aid and audiology device market was valued at over €3.8 billion in 2010, while the wholesale market was valued at almost €1.3 billion The retail market is expected to grow rapidly by 2017 due to aggressive growth strategies among local and international retail chains and the adoption of new technologies such as wireless Bluetooth hearing aids and receiver-in-canal models.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Henri P Lanctin, 1705 Grizzly Ln, Sartell, MN 56377-1693 Ph: () - | Dr Henri P Lanctin, 2351 Connecticut Avenue South, Suite 200, Sartell, MN 56377 Ph: (320) 259-1411 |
News Archive
Getting the word out is half the battle, and the state is well into a $3 million media campaign ... [E]very adult must have insurance by December. If they don't and if the state determines that insurance was affordable for them, they will be fined $219 next year. The penalty increases substantially in 2009.
In the US, child-resistant packaging for most medications has contributed to the prevention of thousands of pediatric deaths. Nevertheless, over 500,000 calls are made to poison control centers each year after accidental ingestion of medications by young children, and the number of emergency department visits for unsupervised medication ingestions is rising.
NicOx S.A. (NYSE Euronext Paris: COX) today announced that an important scientific article has been published in the September issue of the American Journal of Cardiology. The publication describes the blood pressure results from the 301 phase 3 study for naproxcinod in detail. Naproxcinod is the first-in-class Cyclooxygenase-Inhibiting Nitric Oxide Donating (CINOD) anti-inflammatory agent for the relief of the signs and symptoms of osteoarthritis (OA).
According to a new report by iData Research, the leading global authority in medical device and pharmaceutical market research, the retail European hearing aid and audiology device market was valued at over €3.8 billion in 2010, while the wholesale market was valued at almost €1.3 billion The retail market is expected to grow rapidly by 2017 due to aggressive growth strategies among local and international retail chains and the adoption of new technologies such as wireless Bluetooth hearing aids and receiver-in-canal models.
› Verified 3 days ago
Dr. John Kazuo Matsuura, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 2351 Connecticut Ave S, Suite 200, Sartell, MN 56377 Phone: 320-259-1411 Fax: 320-259-8967 | |
Dr. Andrew Peter Windsperger, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 2351 Connecticut Ave S, Suite 200, Sartell, MN 56377 Phone: 320-259-1411 Fax: 320-259-8967 | |
Dr. Albert David Matthew, Urology Medicare: Not Enrolled in Medicare Practice Location: 2351 Connecticut Avenue South, Suite 200, Sartell, MN 56377 Phone: 320-259-1411 | |
Dr. Christopher William Boelter, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 2351 Connecticut Ave S, Suite 200, Sartell, MN 56377 Phone: 320-259-1411 Fax: 320-259-8967 | |
Elizabeth A Phillips, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 2351 Connecticut Ave S, Suite 200, Sartell, MN 56377 Phone: 320-259-1411 | |
Lori Ann Pinke, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 2351 Connecticut Ave S, Suite 200, Sartell, MN 56377 Phone: 320-259-1411 Fax: 320-259-8967 | |
Dr. Shawn Michael Mcgee, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 2351 Connecticut Ave S, Suite 200, Sartell, MN 56377 Phone: 320-259-1411 Fax: 320-259-8967 |